MYO15A Gene Deafness autosomal recessive type 3 Genetic Test
Are you or your loved ones experiencing profound hearing loss from birth? It could be due to autosomal recessive type 3 (DFNB3) deafness caused by the MYO15A gene. At DNA Labs UAE, we offer a comprehensive genetic test to diagnose this condition.
Test Details
The MYO15A gene is associated with autosomal recessive type 3 (DFNB3) deafness. This genetic condition results in profound hearing loss that is present from birth. To identify any mutations or variations in the MYO15A gene that may be causing the deafness, we utilize NGS (Next-Generation Sequencing) technology. NGS genetic testing allows us to analyze multiple genes simultaneously, providing a comprehensive assessment of the MYO15A gene.
Components
- Test Name: MYO15A Gene Deafness autosomal recessive type 3 Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information
Prior to the MYO15A Gene Deafness autosomal recessive type 3 Genetic Test, it is recommended to provide the clinical history of the patient who is going for the SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. Additionally, a genetic counseling session is advised to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A9.
Benefits of Genetic Testing
By identifying the specific genetic mutation responsible for MYO15A gene deafness, NGS genetic testing can help in diagnosing individuals with this condition. This information is crucial for genetic counseling and can guide treatment options, such as the use of hearing aids or cochlear implants.
Conclusion
If you or someone you know is experiencing profound hearing loss from birth, our MYO15A Gene Deafness autosomal recessive type 3 Genetic Test can provide valuable insights. With our advanced NGS technology and expertise in genetics, DNA Labs UAE is dedicated to helping individuals and families understand their genetic conditions and make informed decisions about their healthcare.
Test Name | MYO15A Gene Deafness autosomal recessive type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A9 |
Test Details |
The MYO15A gene is associated with a specific type of deafness known as autosomal recessive type 3 (DFNB3). This condition is characterized by profound hearing loss that is present from birth. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be responsible for a specific condition. In the case of MYO15A gene deafness, an NGS genetic test would involve sequencing the MYO15A gene to identify any mutations or variations that may be causing the autosomal recessive type 3 deafness. By identifying the specific genetic mutation responsible for the condition, NGS genetic testing can help in diagnosing individuals with MYO15A gene deafness. This information can also be used for genetic counseling and to guide treatment options, such as the use of hearing aids or cochlear implants. |